About Invitae
Invitae is a company based in San Francisco (United States) founded in 2010 by Michele Cargill and Sean Emerson George. Invitae has raised $189.56 million across 11 funding rounds from investors including SoftBank Group, Orbimed and Farallon Capital Management. The company has 1,700 employees as of December 31, 2022. Invitae has completed 13 acquisitions, including AltaVoice, ArcherDX and CancerGene Connect. Invitae offers products and services including Oncology Tests, Women's Health Tests, Pediatrics and Rare Diseases Tests, Cardiology Tests, and Neurology Tests. Invitae operates in a competitive market with competitors including Everlywell, Viome, Color, Strand Life Sciences and Genome Medical, among others.
- Headquarter San Francisco, United States
- Employees 1700 as on 31 Dec, 2022
- Founders Michele Cargill, Sean Emerson George
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$516.3 M (USD)12as on Dec 31, 2022
-
Net Profit
-$3.11 B (USD)-720as on Dec 31, 2022
-
EBITDA
-$3.12 B (USD)-696as on Dec 31, 2022
-
Total Equity Funding
$189.56 M (USD)
in 11 rounds
-
Latest Funding Round
$1.15 B (USD), Post-IPO
Apr 05, 2021
-
Investors
SoftBank Group
& 16 more
-
Employee Count
1700
as on Dec 31, 2022
-
Investments & Acquisitions
AltaVoice
& 12 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Invitae
Invitae offers a comprehensive portfolio of products and services, including Oncology Tests, Women's Health Tests, Pediatrics and Rare Diseases Tests, Cardiology Tests, and Neurology Tests.
Genetic tests for cancer risks and diagnostics
Tests for genetic factors in women's health issues
Services for identifying rare genetic conditions in children
Genetic analysis for heart-related conditions
Tests for neurological disorder genetic risks
People of Invitae
Unlock access to complete
Unlock access to complete
Software Development Team
172 people
Leadership Team
143 people
Sales and Marketing
52 people
Product Management Team
38 people
Human Resources and Administration
36 people
Operations Team
33 people
Data Analysis and Operations Team
32 people
Senior Team
29 people
Unlock access to complete
Funding Insights of Invitae
Invitae has successfully raised a total of $189.56M across 11 strategic funding rounds. The most recent funding activity was a Post-IPO round of $1.15 billion completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Invitae
Invitae has secured backing from 17 investors, including institutional and venture fund investors. Prominent investors backing the company include SoftBank Group, Orbimed and Farallon Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple investment strategies are pursued by this hedge fund.
|
Locked | Locked | Locked | |
|
Structured financing solutions are provided for the global healthcare industry by Oberland Capital.
|
Locked | Locked | Locked | |
|
Venture debt firm focused on the life sciences sector
|
Locked | Locked | Locked |
Investor details for Invitae
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Invitae
Invitae has strategically engaged in corporate development activities, having acquired 13 companies. Notable acquisitions include AltaVoice, ArcherDX and CancerGene Connect.
Investment portfolio details for Invitae
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Personal health data is stored, managed, and shared online.
|
Locked | Locked | 2017 | Locked | |
|
Chatbot and telemedicine platform for genetic results interpretation is provided.
|
Locked | Locked | 2016 | Locked | |
|
Provider of technical support services for biopharma industry
|
Locked | Locked | 2016 | Locked |
Complete acquisition details for Invitae
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Invitae
Detailed financials for Invitae
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Invitae Comparisons
Peer comparison for Invitae
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Invitae
Invitae operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Everlywell, Viome, Color, Strand Life Sciences and Genome Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
At-home health tests for biomarkers, nutrition, and hormone analysis.
|
|
| Locked | Locked | Locked |
Machine learning-based bioinformatics solutions for health insights are provided.
|
|
| Locked | Locked | Locked |
Cancer care is delivered through a virtual clinic by Color.
|
|
| Locked | Locked | Locked |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| Locked | Locked | Locked |
Genomic testing services are provided clinically and directly to consumers.
|
Detailed competitors of Invitae
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Invitae
Complete news archive for Invitae
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Invitae
Invitae was founded in 2010 and raised its 1st funding round 2 years after it was founded.
Invitae is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Sean Emerson George is the current CEO of Invitae. They have also founded this company.
Invitae is a funded company, having raised a total of $189.56M across 11 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Invitae is 1,700.
Annual revenue of Invitae is $516.3M as on Dec 31, 2022.
Invitae was founded in 2010 in San Francisco, United States, and operates in the genetic testing sector. Genetic tests are requested online by individuals, with saliva samples collected through assistance from doctors. Diseases are detected via analysis, and results are accessed online for sharing with healthcare providers. The platform supports home-based services focused on personal genetic health assessments.
Invitae's top competitors include Strand Life Sciences, Viome and Fulgent Genetics.
Invitae offers Oncology Tests, Women's Health Tests, Pediatrics and Rare Diseases Tests, Cardiology Tests, and Neurology Tests.
Invitae has made 13 acquisitions, including AltaVoice, ArcherDX, and CancerGene Connect.
Invitae has 17 investors. Key investors include SoftBank Group, Orbimed, Farallon Capital Management, Driehaus, and Oxford Finance.